Medtronic gets FDA approval for new heart-condition treatment

Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions.

Related Keywords

Dublin ,Ireland , ,Drug Administration ,Pulseselect Pulsed Field Ablation System ,Article Normal ,Pharmaceuticals ,Cardiovascular Drugs ,Medical Equipment Supplies ,Health Care ,Specialized Drugs Medications ,Regulation Government Policy ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Cardiovascular Conditions ,Political General News ,Health ,Medical Conditions ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Medtronic Plc ,Mdt ,Regulation ,Government Policy ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Political ,General News ,Medical Equipment ,Supplies ,Specialized Drugs ,Medications ,